SLC6A3 and Parkinson disease: GB34, a key motor acupoint, activates the precentral gyrus and prefrontal cortex in PD patients, enhancing synaptic dopamine availability and upregulating dopamine transporter/D1 receptor expression while normalizing D2 levels in 6-OHDA models (56).